OxTalks is Changing
On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
T-Cell Dynamics in hrHPV Infection: Insights into Immune Control and Therapeutic Vaccination
Bio:
Dr. Karin Hellner is a consultant gynaecologist and researcher at the Nuffield Department of Women’s and Reproductive Health. She has a strong clinical interest in HPV-associated cervical disease and is leading a research program in the field of the molecular basis and clinical management of cervical dysplasia. She is the lead consultant for Oxford’s colposcopy service and Principal Investigator of multiple national and international clinical trials.
Dr. Gemma Hancock is a Senior Postdoctoral Researcher at the Nuffield Department of Women’s and Reproductive Health. She has a background in oncology and immunology, and her current research centres on the immune response to high-risk human papillomavirus (HPV) infections in order to develop therapeutic strategies to enhance immunity against HPV, particularly to prevent cervical cancer
Abstract:
This talk by Gemma and Karin will explore T-cell dynamics in high-risk HPV (hrHPV) infections, focusing on immune responses that facilitate virus clearance and inform therapeutic vaccine design. They will discuss findings from a longitudinal study analysing HPV-specific T cell responses and highlight the therapeutic HPV vaccine they developed, which has entered a clinical trial with Dr. Hellner as Chief Investigator. Insights from this work aim to inform next-generation treatments that could intercept HPV progression to cervical cancer.
Date:
12 November 2024, 13:00
Venue:
This event is hybrid
Speakers:
Dr Gemma Hancock (NDWRH, University of Oxford),
Dr Karin Hellner (NDWRH, University of Oxford)
Organising department:
Nuffield Department of Women's and Reproductive Health
Organiser:
Michael Suttie (NDWRH, University of Oxford)
Organiser contact email address:
seminars@wrh.ox.ac.uk
Booking required?:
Recommended
Booking email:
seminars@wrh.ox.ac.uk
Audience:
Members of the University only
Editor:
Isobel Way
